Answers are grounded in this paper and cite their sources.
Leishmaniasis, a parasitic disease transmitted by sandflies, remains a significant global health concern, particularly in tropical regions. The arginase enzyme ( La Arg) has emerged as a promising therapeutic target in Leishmania amazonensis . This study employs a computer-aided drug design approach to identify novel La Arg inhibitor candidates. A series of 38 compounds featuring a 1 H -pyrazolo[3,4- b ]pyridine nucleus was evaluated using 3D-QSAR (Py-CoMFA), molecular docking, and molecular dynamics simulations to predict pIC 50 values and investigate molecular interactions within the La Arg active site. Our results identified 14 compounds with promising predicted activity (pIC 50 ≥ 5.00). Molecular docking analysis revealed that 10 compounds establish strong interactions with key catalytic residues (His127 and His142) and Mn 2+ ions, which are crucial for La Arg binding. Molecular dynamics further characterized compounds 1b and 1e as potential arginase inhibitors, though they exhibited distinct thermodynamic profiles. Compound 1b , featuring a nitrile group, demonstrated initial stability and a balanced molecular profile. However, it failed to maintain its binding mode throughout the entire simulation trajectory. Conversely, while 1e remained stable at the site, its bromine substituent incurred a significant solvation penalty, leading to a less favorable binding free energy than 1b . These findings provide significant insights into the structural requirements for arginase inhibition and establish a framework for developing novel therapeutic compounds against leishmaniasis.
No takes yet. Share an insight, caveat, or question.
Camargo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: